Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
32 Leser
Artikel bewerten:
(0)

Canada Generic Drug Market 2016 - Drivers, Sales Trends, Prescription Trends, Market Structure & Competitive Landscape - Research and Markets

DUBLIN, June 13, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook" report to their offering.

Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada.

This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Canada represents the world's ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors.

Key Topics Covered:

1 Research Methodology and Market Definitions

2 Report Summary

3 Canada Generic Drug Market - Introduction

4 Why is the Generic Drug Market so Lucrative in Canada

5 Global Generic Drug Market

6 Canada Generic Drug Market

7 Canada Generic Drug Market- Competitive Landscape

8 Canada Generic Drug Market - Value Chain Analysis

9 Canada Generic Drug Market - Regulatory Framework

10 Canada Generic Drug Market: Key Success Factors

11 Canada Generic Drug Market: Road Blocks

12 Requirements for Setting Up a Generic Drug Manufacturing Plant

13 Canada Generic Drug Market - Key Company Profiles
13.1 Teva Pharmaceutical Ltd.
13.2 Apotex Inc.
13.3 Sandoz Canada
13.4 Actavis
13.5 Mylan
13.6 Pharmascience Inc.
13.7 Taro Pharmaceuticals
13.8 Novartis
13.9 Ranbaxy Pharmaceuticals Canada
13.10 Hospira

For more information visit http://www.researchandmarkets.com/research/nfx66d/canada_generic

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.